Skip to main content
Fig. 1 | Molecular Neurodegeneration

Fig. 1

From: Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Fig. 1

Generation of TCR-Tregs. A. Flow cytometry gating confirming the CRISPR-Cas9-mediated knockout of endogenous T cell receptors (TCRs) to generate TCR−−-Tregs. Nucleotide sequences represent the guide RNAs targeting the alpha and beta regions of the TCR. B. Plasmid design for TCR electroporation. C. Representative gating strategy confirming the TCR expression by TCR-Tregs electroporated with 0.5 μL of TCR plasmid (plasmid conc. = 1.5 μg/μL). D. Time course of TCR expression on engineered TCR-Tregs post electroporation with TCR plasmid. Phenotype characterization of engineered TCR-Tregs shown in Supplementary Fig. 3. E. MHCII-IA.b-KLVFFAEDVGSNKGA (Aβ T cell epitope) tetramer binding confirming the Aβ reactivity of engineered TCR-Tregs incubated with Aβ-tetramer (blue) compared to TCR-Tregs incubated with control-tetramer (orange) or polyclonal Tregs incubated with Aβ-Tetramer (red)

Back to article page